Skip to main content

ERRATUM article

Front. Mol. Neurosci., 05 July 2022
Sec. Pain Mechanisms and Modulators
Volume 15 - 2022 | https://doi.org/10.3389/fnmol.2022.979385

Erratum: Long March Toward Safe and Effective Analgesia by Enhancing Gene Expression of Kcc2: First Steps Taken

This article is an erratum on:

  1. Long March Toward Safe and Effective Analgesia by Enhancing Gene Expression of Kcc2: First Steps Taken

    1. Read original article
\n Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Long March Toward Safe and Effective Analgesia by Enhancing Gene Expression of Kcc2: First Steps Taken

by Liedtke, W. (2022). Front. Mol. Neurosci. 15:865600. doi: 10.3389/fnmol.2022.865600

Due to a production error, the “Conflict of Interest” statement incorrectly stated that “WL was a full-time” instead of “WL is a full-time.”

The corrected section should read:

“WL is a full-time executive employee of Regeneron Pharmaceuticals, Tarrytown, NY, United States.”

The publisher apologizes for this mistake. The original version of this article has been updated.

Keywords: pain, spinal cord dorsal horn, KCC2, Kcc2 gene expression enhancer, GSK3, delta-catenin, Kaiso

Citation: Frontiers Production Office (2022) Erratum: Long March Toward Safe and Effective Analgesia by Enhancing Gene Expression of Kcc2: First Steps Taken. Front. Mol. Neurosci. 15:979385. doi: 10.3389/fnmol.2022.979385

Received: 27 June 2022; Accepted: 27 June 2022;
Published: 05 July 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.